Molecular and Evolution

4-HPPD C-terminal tail gating molecular dynamics simulations molecular modeling multiple sequence alignment mutagenesis protein evolution

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 22 04 2024
revised: 21 05 2024
accepted: 24 05 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

The enzyme 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) is involved in the catabolism of the amino acid tyrosine in organisms such as bacteria, plants, and animals. It catalyzes the conversion of 4-hydroxyphenylpyruvate to a homogenisate in the presence of molecular oxygen and Fe(II) as a cofactor. This enzyme represents a key step in the biosynthesis of important compounds, and its activity deficiency leads to severe, rare autosomal recessive disorders, like tyrosinemia type III and hawkinsinuria, for which no cure is currently available. The 4-HPPD C-terminal tail plays a crucial role in the enzyme catalysis/gating mechanism, ensuring the integrity of the active site for catalysis through fine regulation of the C-terminal tail conformation. However, despite growing interest in the 4-HPPD catalytic mechanism and structure, the gating mechanism remains unclear. Furthermore, the absence of the whole 3D structure makes the bioinformatic approach the only possible study to define the enzyme structure/molecular mechanism. Here, wild-type 4-HPPD and its mutants were deeply dissected by applying a comprehensive bioinformatics/evolution study, and we showed for the first time the entire molecular mechanism and regulation of the enzyme gating process, proposing the full-length 3D structure of human 4-HPPD and two novel key residues involved in the 4-HPPD C-terminal tail conformational change.

Identifiants

pubmed: 38927403
pii: biomedicines12061196
doi: 10.3390/biomedicines12061196
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : PNRR-PRIN2022
ID : 2265-2023-SA-PROFCMUR_PNRR-PRIN2022_PC_002

Auteurs

Alfonso Trezza (A)

Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.

Ancuta Birgauan (A)

Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.

Michela Geminiani (M)

Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.
SienabioACTIVE, Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.

Anna Visibelli (A)

Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.

Annalisa Santucci (A)

Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.
SienabioACTIVE, Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro, 53100 Siena, SI, Italy.
ARTES 4.0, Viale Rinaldo Piaggio, 34, 56025 Pontedera, PI, Italy.

Classifications MeSH